Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial

BACKGROUND: Tacrolimus (TAC) is effective in treating membranous nephropathy (MN); however relapses are frequent after treatment cessation. We conducted a randomised controlled trial to examine whether the addition of mycophenolate mofetil (MMF) to TAC would reduce relapse rate. METHODS: Forty patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolopoulou, Aikaterini, Condon, Marie, Turner-Stokes, Tabitha, Cook, H. Terence, Duncan, Neill, Galliford, Jack W., Levy, Jeremy B., Lightstone, Liz, Pusey, Charles D., Roufosse, Candice, Cairns, Thomas D., Griffith, Megan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731553/
https://www.ncbi.nlm.nih.gov/pubmed/31492152
http://dx.doi.org/10.1186/s12882-019-1539-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731553/
https://www.ncbi.nlm.nih.gov/pubmed/31492152
http://dx.doi.org/10.1186/s12882-019-1539-z

Ejemplares similares